Sequential Administration of GM-CSF (Sargramostim®) and IL-2 ± Autologous Vaccine as Adjuvant Therapy in Cutaneous Melanoma: An Interim Report of a Phase II Clinical Trial
Sequential Administration of GM-CSF (Sargramostim®) and IL-2 ± Autologous Vaccine as Adjuvant Therapy in Cutaneous Melanoma: An Interim Report of a Phase II Clinical Trial
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search